S. Pomer

2.7k total citations
51 papers, 722 citations indexed

About

S. Pomer is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, S. Pomer has authored 51 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 15 papers in Surgery. Recurrent topics in S. Pomer's work include Renal cell carcinoma treatment (15 papers), Renal Transplantation Outcomes and Treatments (11 papers) and Cancer Immunotherapy and Biomarkers (8 papers). S. Pomer is often cited by papers focused on Renal cell carcinoma treatment (15 papers), Renal Transplantation Outcomes and Treatments (11 papers) and Cancer Immunotherapy and Biomarkers (8 papers). S. Pomer collaborates with scholars based in Germany, United States and Netherlands. S. Pomer's co-authors include G. Staehler, D. Brkovic, Hiltrud Brauch, Gerd Staehler, M. Rotter, Juergen Brieger, Gregor Weirich, Damjan Glavač, A Masera and Peter Schirmacher and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and European Urology.

In The Last Decade

S. Pomer

51 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Pomer Germany 13 353 326 175 159 147 51 722
Nikolaos Soulitzis Greece 14 216 0.6× 409 1.3× 141 0.8× 92 0.6× 265 1.8× 28 768
R. E. Millikan United States 7 135 0.4× 302 0.9× 124 0.7× 187 1.2× 182 1.2× 13 595
Jung‐Sun Kim South Korea 13 342 1.0× 489 1.5× 112 0.6× 290 1.8× 157 1.1× 18 948
Andrew Sherrod United States 13 257 0.7× 331 1.0× 103 0.6× 125 0.8× 529 3.6× 21 1.0k
Giovanni Casetta Italy 17 152 0.4× 345 1.1× 241 1.4× 427 2.7× 154 1.0× 50 887
S. Melchior Germany 11 380 1.1× 336 1.0× 136 0.8× 139 0.9× 149 1.0× 34 672
Sadao Yoshida Japan 13 256 0.7× 196 0.6× 95 0.5× 399 2.5× 336 2.3× 29 796
Rozelle Harvie Australia 15 298 0.8× 261 0.8× 106 0.6× 83 0.5× 367 2.5× 28 806
Eriko Miyazaki Japan 17 180 0.5× 256 0.8× 58 0.3× 170 1.1× 103 0.7× 55 663
A Grant United Kingdom 11 195 0.6× 146 0.4× 76 0.4× 148 0.9× 168 1.1× 16 530

Countries citing papers authored by S. Pomer

Since Specialization
Citations

This map shows the geographic impact of S. Pomer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Pomer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Pomer more than expected).

Fields of papers citing papers by S. Pomer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Pomer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Pomer. The network helps show where S. Pomer may publish in the future.

Co-authorship network of co-authors of S. Pomer

This figure shows the co-authorship network connecting the top 25 collaborators of S. Pomer. A scholar is included among the top collaborators of S. Pomer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Pomer. S. Pomer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bubeck, B., Wolfgang Brandau, E. Weber, et al.. (2015). Renal Function Studies Using 99mTc-MAG3: Pharmacokinetics and Slope Clearance Determination. Contributions to nephrology. 79. 72–73. 3 indexed citations
2.
Lutz, Norbert W., et al.. (2005). Investigation of multidrug resistance in cultured human renal cell carcinoma cells by 31P-NMR spectroscopy and treatment survival assays. Magnetic Resonance Materials in Physics Biology and Medicine. 18(3). 144–161. 12 indexed citations
3.
Pomer, S. & Zbysław Dobrowolski. (2002). The therapy of benign prostatic hyperplasia using less‐invasive procedures: the current situation. British Journal of Urology. 89(7). 773–775. 6 indexed citations
4.
5.
Hallscheidt, Peter, S. Pomer, T Roeren, G. W. Kauffmann, & G. Staehler. (2000). Präoperatives Staging von Nierenzellkarzinomen mit Kavazapfen: welches diagnostische Verfahren?. Der Urologe. 39(1). 36–40. 16 indexed citations
6.
Pitzer, Claudia, Katharina Schindowski, S. Pomer, Thomas Wirth, & Margot Zöller. (1999). In vivo manipulation of interleukin-2 expression by a retroviral tetracycline (tet)-regulated system. Cancer Gene Therapy. 6(2). 139–146. 9 indexed citations
7.
Frank, Markus H. & S. Pomer. (1999). Interferon α2b differentially affects proliferation of two human renal cell carcinoma cell lines differing in the P-glycoprotein-associated multidrug-resistant phenotype. Journal of Cancer Research and Clinical Oncology. 125(2). 117–120. 6 indexed citations
8.
Pomer, S., et al.. (1997). Hirnmetastasierung beim Nierenzellkarzinom Behandlungsergebnisse und Prognose. Der Urologe. 36(2). 117–125. 7 indexed citations
9.
Pomer, S., et al.. (1997). Hirnmetastasierung beim Nierenzellkarzinom. Der Urologe. 36(2). 117–125. 7 indexed citations
10.
Brkovic, D., et al.. (1997). Surgical Treatment of InvasivePenile Cancer - The HeidelbergExperience from 1968 to 1994. European Urology. 31(3). 339–342. 23 indexed citations
11.
Brkovic, D., et al.. (1996). Aetiology, Diagnosis andManagement of SpontaneousPerirenal Haematomas. European Urology. 29(3). 302–307. 51 indexed citations
12.
13.
Schirrmacher, Volker, Thomas Lehnert, S. Pomer, et al.. (1995). Biotherapy of cancer. Journal of Cancer Research and Clinical Oncology. 121(8). 443–451. 9 indexed citations
14.
15.
Pomer, S., et al.. (1994). Fibrin-glue vasovasostomy as an alternative to the conventional two-layer suture technique?. PubMed. 5. 253–5. 3 indexed citations
16.
Brauch, Hiltrud, et al.. (1994). Genetic alterations in sporadic renal-cell carcinoma: molecular analyses of tumor suppressor gene harboring chromosomal regions 3p, 5q, and 17p. World Journal of Urology. 12(3). 162–8. 28 indexed citations
17.
Pomer, S., et al.. (1993). Magnetic resonance in nephrourology : clinical and experimental applications. Springer eBooks. 2 indexed citations
18.
Daniel, Volker, et al.. (1991). Hepatitis C-virus (HCV) antibodies in patients after kidney transplantation. Annals of Hematology. 62(2-3). 68–73. 14 indexed citations
19.
Ruder, H., J. Strehlau, Franz Schaefer, et al.. (1989). Low-dose cyclosporin A therapy in cadaver renal transplantation in children. Transplant International. 2(1). 203–208. 4 indexed citations
20.
Pomer, S., et al.. (1988). Assessment of renal viability for transplantation by high field 31P-NMR.. PubMed. 20(5). 899–901. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nikolaos Soulitzis Breakdown of academic impact, for papers by R. E. Millikan Breakdown of academic impact, for papers by Jung‐Sun Kim Breakdown of academic impact, for papers by Andrew Sherrod Breakdown of academic impact, for papers by Giovanni Casetta Breakdown of academic impact, for papers by S. Melchior Breakdown of academic impact, for papers by Sadao Yoshida Breakdown of academic impact, for papers by Rozelle Harvie Breakdown of academic impact, for papers by Eriko Miyazaki Breakdown of academic impact, for papers by A Grant
Rankless by CCL
2026